Results

Total Results: 123 records

Showing results for "statin".
Users also searched for: statin

41. Methods-Guide-Chapter-Prioritization-And-Selection-Of-Harms-For-Inclusion-In-Systematic-Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
    February 01, 2018 - difficult to distinguish harms from failed treatments (e.g., myocardial infarction in patients on statin … toxicity Biopsy: bleeding; nosocomial infection Combination Therapy Versus Intensification of Statin … Dual agent therapy (statin + lipid modifying medication) and intensification of statin therapy

42. AHRQ Slide Template 2009 (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
    August 01, 2009 - AHRQ Slide Template 2009 Presentation of Findings Agency for Healthcare Research and Quality (AHRQ) Training Modules for Methods Guide for Effectiveness and Comparative Effectiveness Reviews Presentation of Findings Systematic Review Process Overview Systematic Review Process Overview This slide illustrates th…

43. Ch 4-User-Guide-To-Ocer 130129 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - As noted in the statin example above, the exposure time window to evaluate the effectiveness of statins

44. Disposition of Comments for Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
    April 22, 2013 - screening and monitoring of measures such as weight and blood pressure and a potentially increase role in statin

45. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
    January 01, 2013 - Statin adherence and risk of accidents: a cautionary tale. Circulation 2009 Apr 21;119(15):2051-7. … The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in

46. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Evidence Report on the Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening for and Management of Chronic Kidney Disease Stages 1-3 I. Background and Objectives for the Systematic Review T…

47. Methods Guide Atkins (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
    January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … of differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin

48. Methods-Guidance-Applicability Methods (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
    January 01, 2011 - For example, the individual trials of statin drugs to treat high cholesterol each selected specific … of differing risks, nationalities, and underlying conditions provides evidence that the benefits of statin

49. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
    March 10, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: March 10, 2010 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors…

50. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
    January 01, 2013 - Slide 1 Exposure Definition and Measurement in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Exposure Definition and Measurement in Observational Comparative Effectiveness Research This slide set is based on a user guide titled Develop…

51. Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
    March 01, 2013 - Methods Guide for Comparative Effectiveness Reviews - Expanded Guidance on Selected Quantitative Synthesis Topics Methods Guide for Comparative Effectiveness Reviews Expanded Guidance on Selected Quantitative Synthesis Topics ii This report is based on research conducted by the Tufts…

52. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
    July 01, 2017 - Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Focus of This Summary This is a summary of a systematic review that evaluated the recent evidence regarding the effects of omega-3 fatty acids (FAs), primaril…

53. Microsoft Word - finbody.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - Microsoft Word - finbody.doc This report is based on research conducted by the Tufts-New England Medical Center Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-02-0022). The findings and conclusions in this d…

54. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
    November 01, 2007 - blockers, α-adrenergic receptor antagonists, 3-hydroxy- methylglutaryl-coenzyme A reductase inhibitors (statin … 41.5) 583 (37.6) 0.003 α-adrenergic receptor antagonist 2,193 (19.2) 2,035 (20.7) 158 (10.2) <0.001 Statin … 1,241 (36.9) <0.001 α-adrenergic receptor antagonist 2,193 (19.2) 1,692 (21.1) 501 (14.9) <0.001 Statin … 1.30 (1.10-1.52) Digoxin 1.24 (1.12-1.38) Diuretic 1.54 (1.37-1.73) Nitrate 1.63 (1.47-1.82) Statin … 25.2)‡ 269 (49.3) α-adrenergic receptor antagonist 674 (21.8) 701 (20.2) 125 (13.4)‡ 143 (26.2)* Statin

55. Frazee-notes-151006 copy - Teresa (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/frazee-presentation.pdf
    May 29, 2025 - Frazee-notes-151006 copy - Teresa So thank you very much.   I'm taking a little bit  of a different  tactic on this, but   I want  to say I'm in  agreement with  both  Dr. Hibbard  and  Dr. Fagerlin.  I think we just  take different   approaches to the same information, which is what makes t…

56. Research White Paper - Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
    September 01, 2015 - Preoperative statin therapy for patients undergoing cardiac surgery.

57. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
    October 01, 2019 - Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD Purpose of Review To evaluate the effectiveness and harms of pharmacologic and nonpharmacologic treatments for exacerbations of chronic obstructive pulmonary disease. Key Messages • Antibiotic therapy in…

58. An analytical framework for quantifying components of variability in prescriber decisions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
    April 01, 2010 - If an instrument for statin prescribing also affects the prescribing of the other medications, the … IV approach may be biased for the effect of statin exposure.

59. Rheumatoid-Arthritis-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Those taking anakinra and concomitant diabetic, antihypertensive, or statin medications did not have

60. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
    October 01, 2022 - Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. … Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N Engl J Med.